1) Pro urokinase
人尿激酶原
1.
The Construction and Expression of Human Pro urokinase cDNA Coding Deleted Mutant at 150～156 Amino Acids;
人尿激酶原cDNA序列缺失突变体的构建及表达
2) recombinant human prourokinase
重组人尿激酶原
1.
A new thrombolytic drug:recombinant human prourokinase;
新型溶栓药物重组人尿激酶原
2.
Objective:To study the stability of lyophilized recombinant human prourokinase(rhPro-UK).
目的:探讨重组人尿激酶原(rhPro-UK)冻干产品的稳定性。
3) Recombinant human pro-urokinase
重组人尿激酶原
1.
Study of long term toxicity of recombinant human pro-urokinase in rhesus monkeys;
重组人尿激酶原对恒河猴的长期毒性研究
4) scu PA cDNA
人尿激酶原cDNA
5) Human urinary kallikrein
人尿激肽原酶
1.
CONCLUSION: Human urinary kallikrein for acute cerebral infarction can transiently down-regulate blood pressure slightly,but its effect on blood pressure can be lowered by suitable reduction of its concentration;at any concentration,it can result in hypotension if used in combination with ACEI.
目的:研究不同浓度人尿激肽原酶治疗急性脑梗死对患者血压的影响。
6) prourokinase
尿激酶原
1.
Preparation of monoclonal antibodies specific for prourokinase with synthetic peptide;
用合成多肽免疫制备尿激酶原单克隆抗体
2.
Effects of serum concentration and dissovled oxygen on production of prourokinase with rCHO cell culture;
血清浓度及溶氧对培养rCHO细胞生产尿激酶原的影响
3.
Expression of Prourokinase in Different Mammalian Cells;
不同哺乳动物细胞表达尿激酶原的研究
补充资料：肾性葡萄糖尿氨基酸尿磷酸盐尿症
肾性葡萄糖尿氨基酸尿磷酸盐尿症
renal glucosuria aminoaciduria and phosphaturia
又称“Fanconi综合征”。遗传性或获得性近端肾小管多种功能异常疾病。临床上表现为肾性糖尿、全氨基酸尿、磷酸盐尿、高血氯性代谢性酸中毒、低血钾、多尿及肾小管性蛋白尿等。遗传性Fanconi综合征又可分为成人型及婴儿型两类，后者又称为“de-Toni-Debre-Fanconi综合征”或“Lignac-Fonconi综合征”。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条